Saks Samuel R 4
4 · Protagonist Therapeutics, Inc · Filed Mar 4, 2019
Insider Transaction Report
Form 4
Saks Samuel R
Chief Development Officer
Transactions
- Award
Common Stock
2019-02-28+2,500→ 2,500 total - Award
Stock Option (right to buy)
2019-02-28+15,000→ 15,000 totalExercise: $8.02Exp: 2029-02-27→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]Represents grant of the restricted stock units payable solely in common stock that vest in equal annual installments over four years from the grant date.
- [F2]The stock option vests in 48 equal monthly installments following the date of grant.